Work

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy

Year: 2018

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-018-4884-x

Authors: Yismeilin R. Feliz-Mosquea, Ashley A. Christensen, Adam S. Wilson, Brian Westwood, Jasmina Varagic, Giselle C. Meléndez, Anthony L. Schwartz, Qing-Rong Chen, Lesley Mathews Griner, Rajarshi Guha, Craig J. Thomas, Marc Ferrer, Maria J. Merino, Katherine L. Cook, David D. Roberts, David R. Soto-Pantoja

Institutions: Wake Forest University Health Sciences, Wake Forest University, Wake Forest Baptist Comprehensive Cancer Center, National Institutes of Health, National Cancer Institute, Center for Cancer Research, National Center for Advancing Translational Sciences, Atrium Health Wake Forest Baptist

Language: English

Topic: Phagocytosis and Immune Regulation

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Center for Advancing Translational Sciences, Wake Forest Clinical and Translational Science Institute, Wake Forest School of Medicine

Awards: G2036688879, G424083508, G6056247560, Cellular Interactions with Thrombospondin, G94668252

OpenAlex ID: W2882970743

FWCI: 2.354

Cites: 56

Cited by: 58

Related to: 10